ZIBO QIXIANG TENGDA CHEMICAL CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.39 CNY | +0.37% |
|
+2.67% | +2.08% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 12,142 | 12,627 | 14,615 | 29,847 | 20,013 | 15,010 |
| Enterprise Value (EV) 1 | 13,128 | 14,718 | 17,513 | 34,499 | 26,162 | 21,394 |
| P/E ratio | 14.6 x | 20.4 x | 17.1 x | 12.7 x | 33.5 x | -40.6 x |
| Yield | 1.32% | 1.12% | 3.01% | - | 2.27% | 1.34% |
| Capitalization / Revenue | 0.43 x | 0.42 x | 0.59 x | 0.86 x | 0.67 x | 0.56 x |
| EV / Revenue | 0.47 x | 0.49 x | 0.71 x | 0.99 x | 0.88 x | 0.79 x |
| EV / EBITDA | 8.56 x | 9.87 x | 7.95 x | 8.31 x | 11.1 x | 9.54 x |
| EV / FCF | 39.4 x | 62.1 x | 47.2 x | -11.1 x | -10.5 x | 19.9 x |
| FCF Yield | 2.54% | 1.61% | 2.12% | -9.05% | -9.48% | 5.04% |
| Price to Book | 1.67 x | 1.65 x | 1.63 x | 2.33 x | 1.48 x | 1.27 x |
| Nbr of stocks (in thousands) | 2,485,293 | 2,472,392 | 2,447,529 | 2,842,607 | 2,842,785 | 2,842,839 |
| Reference price 2 | 4.886 | 5.107 | 5.971 | 10.50 | 7.040 | 5.280 |
| Announcement Date | 3/25/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 27,924 | 30,058 | 24,686 | 34,892 | 29,810 | 26,918 |
| EBITDA 1 | 1,534 | 1,491 | 2,202 | 4,151 | 2,354 | 2,242 |
| EBIT 1 | 983.8 | 812.3 | 1,428 | 3,110 | 1,139 | 456.7 |
| Operating Margin | 3.52% | 2.7% | 5.78% | 8.91% | 3.82% | 1.7% |
| Earnings before Tax (EBT) 1 | 976.7 | 707.6 | 1,208 | 2,806 | 718 | -511.4 |
| Net income 1 | 842.9 | 620.5 | 975.7 | 2,393 | 633.8 | -383.7 |
| Net margin | 3.02% | 2.06% | 3.95% | 6.86% | 2.13% | -1.43% |
| EPS 2 | 0.3357 | 0.2500 | 0.3500 | 0.8300 | 0.2100 | -0.1300 |
| Free Cash Flow 1 | 333.5 | 237.1 | 371 | -3,122 | -2,481 | 1,078 |
| FCF margin | 1.19% | 0.79% | 1.5% | -8.95% | -8.32% | 4% |
| FCF Conversion (EBITDA) | 21.75% | 15.9% | 16.85% | - | - | 48.07% |
| FCF Conversion (Net income) | 39.57% | 38.21% | 38.02% | - | - | - |
| Dividend per Share 2 | 0.0643 | 0.0571 | 0.1796 | - | 0.1600 | 0.0706 |
| Announcement Date | 3/25/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 985 | 2,091 | 2,898 | 4,652 | 6,148 | 6,383 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.6423 x | 1.402 x | 1.316 x | 1.121 x | 2.612 x | 2.847 x |
| Free Cash Flow 1 | 334 | 237 | 371 | -3,122 | -2,481 | 1,078 |
| ROE (net income / shareholders' equity) | 12% | 8.07% | 11.4% | 21.1% | 4.35% | -3.47% |
| ROA (Net income/ Total Assets) | 5.81% | 3.96% | 5.13% | 8.32% | 2.59% | 1.02% |
| Assets 1 | 14,504 | 15,672 | 19,012 | 28,750 | 24,506 | -37,490 |
| Book Value Per Share 2 | 2.930 | 3.090 | 3.670 | 4.500 | 4.740 | 4.160 |
| Cash Flow per Share 2 | 0.4300 | 0.6200 | 1.440 | 0.9200 | 0.9200 | 1.100 |
| Capex 1 | 314 | 922 | 2,165 | 5,782 | 4,633 | 2,313 |
| Capex / Sales | 1.12% | 3.07% | 8.77% | 16.57% | 15.54% | 8.59% |
| Announcement Date | 3/25/19 | 4/24/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.08% | 2.11B | |
| +2.56% | 102B | |
| -1.92% | 66.01B | |
| +47.62% | 41.76B | |
| +15.99% | 38.66B | |
| +4.25% | 32.28B | |
| +8.78% | 19.57B | |
| +12.32% | 16.77B | |
| +17.69% | 15.08B | |
| +8.31% | 14.83B |
- Stock Market
- Equities
- 002408 Stock
- Financials Zibo Qixiang Tengda Chemical Co., Ltd
